Nikolayevska, Olga http://orcid.org/0000-0003-2784-0205
Conradi, Lenard
Schirmer, Johannes
Reichenspurner, Hermann
Deuschl, Florian
Blankenberg, Stefan
Schäfer, Ulrich
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 25 October 2022
Accepted: 3 March 2023
First Online: 5 April 2023
Declarations
:
: O. Nikolayevska, J. Schirmer and S. Blankenberg have no relevant financial or non-financial interests to disclose. L. Conradi has served on advisory boards for Medtronic, Abbott Vascular, JenaValve Technology, Neovasc Medical and the speaker bureau of Edwards Lifesciences, BostonScientific, Microinterventions, LivaNova and New Valve Technology. U. Schäfer has served on advisory boards for Abbott and New Valve Technology and the speaker bureau of Edwards Lifesciences, BostonScientific, New Valve Technology and Abbott Vascular. H. Reichenspurner received consulting fees from Medtronic Inc., and support for attending meetings and/or travel by Medtronic Inc., F. Deuschl is a full-time employee at at Edwards Lifesciences since October 2018 and received Grant Support for the VIVALL Study.